Related Experiment Video

Updated: May 10, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Towards sustained silencing of HER2/neu in cancer by epigenetic editing

Fahimeh Falahi1, Christian Huisman, Hinke G Kazemier

  • 1University Medical Center Groningen, Groningen, 9713 GZ, the Netherlands. m.g.rots@umcg.nl.

Molecular Cancer Research : MCR
|July 2, 2013
PubMed
Abstract

Insights

Epigenetic editing suppressed human epidermal growth factor receptor-2 (HER2) expression by targeting its DNA. This novel approach reduced cancer cell activity and shows promise for optimizing cancer therapies.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Human epidermal growth factor receptor-2 (HER2) is overexpressed in various cancers.
  • Current therapies targeting HER2 protein show efficacy but can be improved by reducing HER2 expression at the DNA level.

Purpose of the Study:

  • To suppress HER2 expression by inducing epigenetic silencing marks on the HER2 promoter using epigenetic editing.
  • To evaluate the efficacy of zinc finger protein (ZFP)-based epigenetic editing in downregulating HER2 expression and its impact on cancer cells.

Main Methods:

  • HER2 expression and promoter epigenetic modifications were analyzed in ovarian and breast cancer cell lines.
  • Cancer cells were transduced with a HER2-targeting ZFP fused to histone methyltransferases (G9a, SUV39-H1) or a KRAB domain (SKD).
  • Epigenetic marks (H3K9me2, H3ac) and HER2 expression levels were assessed, alongside cellular metabolic activity and clonogenicity.

Main Results:

  • HER2-ZFP fused to G9a successfully induced H3K9me2, leading to significant HER2 downregulation.
  • SKD-mediated downregulation correlated with reduced H3ac.
  • Downregulation of HER2 inhibited cellular metabolic activity and clonogenicity.
  • Genome-wide analysis confirmed preferential ZFP binding to the target sequence.

Conclusions:

  • Epigenetic editing can effectively induce silencing histone methylation marks (H3K9me2) and reduce active marks (H3ac) to suppress oncogene expression.
  • This study demonstrates the potential of epigenetic editing to downregulate HER2 expression, offering a novel approach for cancer therapy.

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...